Suppressor of cytokine signaling-3 and intimal hyperplasia in porcine coronary arteries following coronary intervention

Experimental and Molecular Pathology

Volumn 91, Issue 1, 2011, Pages 346-352

  Gupta, Gaurav K ^a   Dhar, Kajari ^a   Del Core, Michael G ^a   Hunter, William J ^a   Hatzoudis, Georgios I ^a   Agrawal, Devendra K ^a  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Angioplasty; Coronary Intervention; Inflammation; Intimal hyperplasia; Restenosis; Suppressor of cytokine signaling 3

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CYCLINE; SOMATOMEDIN C; SUPPRESSOR OF CYTOKINE SIGNALING 3; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTICLE; CELL PROLIFERATION; CHOLESTEROL DIET; CONTROLLED STUDY; CORONARY ARTERY; DOWN REGULATION; FEMALE; HISTOLOGY; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; NEOINTIMA; NONHUMAN; PERCUTANEOUS CORONARY INTERVENTION; PROTEIN EXPRESSION; SWINE; TRANSLUMINAL CORONARY ANGIOPLASTY; WESTERN BLOTTING;

ACTINS; ANGIOPLASTY, BALLOON, CORONARY; ANIMALS; CELL PROLIFERATION; CELLS, CULTURED; CHOLESTEROL, DIETARY; CORONARY VESSELS; DISEASE MODELS, ANIMAL; FEMALE; HYPERPLASIA; INSULIN-LIKE GROWTH FACTOR I; MUSCLE, SMOOTH, VASCULAR; PROLIFERATING CELL NUCLEAR ANTIGEN; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; SWINE; SWINE, MINIATURE; TUMOR NECROSIS FACTOR-ALPHA; TUNICA INTIMA;

ANIMALIA; SUIDAE; SUS;

EID: 79955767291     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2011.04.004     Document Type: Article

References (35)

1. Allen T.R., Krueger K.D., Hunter W.J., Agrawal D.K. Evidence that insulin-like growth factor-1 requires protein kinase C-epsilon, PI3-kinase and mitogen-activated protein kinase pathways to protect human vascular smooth muscle cells from apoptosis. Immunol. Cell Biol. 2005, 83:651-667.
2. Bedoui S., Velkoska E., Bozinovski S., Jones J.E., Anderson G.P., Morris M.J. Unaltered TNF-alpha production by macrophages and monocytes in diet-induced obesity in the rat. J. Inflamm. 2005, 2:2. Lond.
3. Bode J.G., Nimmesgern A., Schmitz J., Schaper F., Schmitt M., Frisch W., Haussinger D., Heinrich P.C., Graeve L. LPS and TNFalpha induce SOCS3 mRNA and inhibit IL-6-induced activation of STAT3 in macrophages. FEBS Lett. 1999, 463:365-370.
4. Cheng J., Du J. Mechanical stretch simulates proliferation of venous smooth muscle cells through activation of the insulin-like growth factor-1 receptor. Arterioscler. Thromb. Vasc. Biol. 2007, 27:1744-1751.
5. Dalpke A.H., Opper S., Zimmermann S., Heeg K. Suppressors of cytokine signaling (SOCS)-1 and SOCS-3 are induced by CpG-DNA and modulate cytokine responses in APCs. J. Immunol. 2001, 166:7082-7089.
6. Ehlting C., Lai W.S., Schaper F., Brenndorfer E.D., Matthes R.J., Heinrich P.C., Ludwig S., Blackshear P.J., Gaestel M., Haussinger D., Bode J.G. Regulation of suppressor of cytokine signaling 3 (SOCS3) mRNA stability by TNF-alpha involves activation of the MKK6/p38MAPK/MK2 cascade. J. Immunol. 2007, 178:2813-2826.
7. Frystyk J., Ledet T., Moller N., Flyvbjerg A., Orskov H. Cardiovascular disease and insulin-like growth factor I. Circulation 2002, 106:893-895.
8. Goy J.J., Eeckhout E. Intracoronary stenting. Lancet 1998, 351:1943-1949.
9. Grant M.B., Wargovich T.J., Bush D.M., Player D.W., Caballero S., Foegh M., Spoerri P.E. Expression of IGF-1, IGF-1 receptor and TGF-beta following balloon angioplasty in atherosclerotic and normal rabbit iliac arteries: an immunocytochemical study. Regul. Pept. 1999, 79:47-53.
10. Hansson G.K. Inflammation, atherosclerosis, and coronary artery disease. N. Engl. J. Med. 2005, 352:1685-1695.
11. Heinrich P.C., Behrmann I., Haan S., Hermanns H.M., Muller-Newen G., Schaper F. Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem. J. 2003, 374:1-20.
12. Hinohara T. Percutaneous coronary intervention: current perspective. Keio J. Med. 2001, 50:152-160.
13. Hojo Y., Ikeda U., Katsuki T., Mizuno O., Fukazawa H., Kurosaki K., Fujikawa H., Shimada K. Interleukin 6 expression in coronary circulation after coronary angioplasty as a risk factor for restenosis. Heart 2000, 84:83-87.
14. Ihle J.N. The Stat family in cytokine signaling. Curr. Opin. Cell Biol. 2001, 13:211-217.
15. Inoue S., Koyama H., Miyata T., Shigematsu H. Pathogenetic heterogeneity of in-stent lesion formation in human peripheral arterial disease. J. Vasc. Surg. 2002, 35:672-678.
16. Jeremy J.Y., Thomas A.C. Animal models for studying neointima formation. Curr. Vasc. Pharmacol. 2010, 8:198-219.
17. Jia G., Mitra A.K., Cheng G., Gangahar D.M., Agrawal D.K. Angiotensin II and IGF-1 regulate connexin43 expression via ERK and p38 signaling pathways in vascular smooth muscle cells of coronary artery bypass conduits. J. Surg. Res. 2007, 142:137-142.
18. Jia G., Aggarwal A., Tyndall S.H., Agrawal D.K. Tumor necrosis factor-alpha regulates p27 kip expression and apoptosis in smooth muscle cells of human carotid plaques via forkhead transcription factor O1. Exp. Mol. Pathol. 2010, 90:1-8.
19. Kozinski M., Krzewina-Kowalska A., Kubica J., Zbikowska-Gotz M., Dymek G., Piasecki R., Sukiennik A., Grzesk G., Bogdan M., Chojnicki M., Dziedziczko A., Sypniewska G. Percutaneous coronary intervention triggers a systemic inflammatory response in patients treated for in-stent restenosis - comparison with stable and unstable angina. Inflamm. Res. 2005, 54:187-193.
20. Krueger K.D., Mitra A.K., Del Core M., Hunter W.J., Agrawal D.K. A comparison of stent-induced stenosis in coronary versus peripheral arteries. J. Clin. Pathol. 2006, 59:575-579.
21. Libby P. Inflammation in atherosclerosis. Nature 2002, 420:868-874.
22. Libby P., Ridker P.M., Maseri A. Inflammation and atherosclerosis. Circulation 2002, 105:1135-1143.
23. Lincoff A.M., Kereiakes D.J., Mascelli M.A., Deckelbaum L.I., Barnathan E.S., Patel K.K., Frederick B., Nakada M.T., Topol E.J. Abciximab suppresses the rise in levels of circulating inflammatory markers after percutaneous coronary revascularization. Circulation 2001, 104:163-167.
24. Miller A.M., McPhaden A.R., Preston A., Wadsworth R.M., Wainwright C.L. TNFalpha increases the inflammatory response to vascular balloon injury without accelerating neointimal formation. Atherosclerosis 2005, 179:51-59.
25. Monraats P.S., Pires N.M., Schepers A., Agema W.R., Boesten L.S., de Vries M.R., Zwinderman A.H., de Maat M.P., Doevendans P.A., de Winter R.J., Tio R.A., Waltenberger J., t Hart L.M., Frants R.R., Quax P.H., van Vlijmen B.J., Havekes L.M., van der Laarse A., van der Wall E.E., Jukema J.W. Tumor necrosis factor-alpha plays an important role in restenosis development. FASEB J. 2005, 19:1998-2004.
26. Rakesh K., Agrawal D.K. Cytokines and growth factors involved in apoptosis and proliferation of vascular smooth muscle cells. Int. Immunopharmacol. 2005, 5:1487-1506.
27. Roller R.E., Janisch S., Kvas E., Schnedl W.J., Binder B.R., Wojta J., Korninger C. Smooth muscle cell migration promoting activity of plasma predicts restenosis in patients with peripheral arterial occlusive disease undergoing angioplasty. Thromb. Haemost. 2000, 84:1113-1116.
28. Roller R.E., Nimmrichter V., Trinker M., Seinost G., Schnedl W.J., Pilger E. Oxidative stress during peripheral angioplasty. Implication for late restenosis?. Int. Angiol. 2001, 20:131-135.
29. Shai S.Y., Sukhanov S., Higashi Y., Vaughn C., Kelly J., Delafontaine P. Smooth muscle cell-specific insulin-like growth factor-1 overexpression in Apoe-/- mice does not alter atherosclerotic plaque burden but increases features of plaque stability. Arterioscler. Thromb. Vasc. Biol. 2010, 30:1916-1924.
30. Standley P.R., Obards T.J., Martina C.L. Cyclic stretch regulates autocrine IGF-I in vascular smooth muscle cells: implications in vascular hyperplasia. Am. J. Physiol. 1999, 276:E697-E705.
31. Stoiber D., Kovarik P., Cohney S., Johnston J.A., Steinlein P., Decker T. Lipopolysaccharide induces in macrophages the synthesis of the suppressor of cytokine signaling 3 and suppresses signal transduction in response to the activating factor IFN-gamma. J. Immunol. 1999, 163:2640-2647.
32. Suzuki Y., Lyons J.K., Yeung A.C., Ikeno F. The porcine restenosis model using thermal balloon injury: comparison with the model by coronary stenting. J. Invasive Cardiol. 2008, 20:142-146.
33. Thorpe P.E., Hunter W.J., Zhan X.X., Dovgan P.S., Agrawal D.K. A non-injury, diet-induced swine model of atherosclerosis for cardiovascular-interventional research. Angiology 1996, 47:849-858.
34. Thorpe P.E., Zhan X.X., Agrawal D.K., Hunter W.J., Farb A., Virmani R. Multiple arterial injuries and prolonged cholesterol feeding do not increase percent lumen stenosis: impact of compensatory enlargement in the microswine model. Cardiovasc. Pathol. 1998, 7:1-8.
35. Toutouzas K., Colombo A., Stefanadis C. Inflammation and restenosis after percutaneous coronary interventions. Eur. Heart J. 2004, 25:1679-1687.